The Research and Development team at CytomX is dedicated to advancing the Probody® therapeutic platform through innovative scientific research, drug discovery, and development processes. Comprising experts across various disciplines, including protein sciences, translational science, and quantitative systems pharmacology, the team collaborates to design, test, and optimize novel cancer treatments, ultimately aiming to improve patient outcomes in oncology.